KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Non Operating Income (2016 - 2026)

Merck has reported Non Operating Income over the past 18 years, most recently at -$138.0 million for Q1 2026.

  • Quarterly Non Operating Income fell 494.29% to -$138.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$325.0 million through Mar 2026, down 1260.71% year-over-year, with the annual reading at -$151.0 million for FY2025, 729.17% down from the prior year.
  • Non Operating Income was -$138.0 million for Q1 2026 at Merck, up from -$432.0 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $238.0 million in Q3 2025 and troughed at -$708.0 million in Q1 2022.
  • The 5-year median for Non Operating Income is -$89.0 million (2023), against an average of -$131.1 million.
  • Year-over-year, Non Operating Income tumbled 525.24% in 2022 and then skyrocketed 228.57% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $75.0 million in 2022, then crashed by 204.0% to -$78.0 million in 2023, then tumbled by 62.82% to -$127.0 million in 2024, then plummeted by 240.16% to -$432.0 million in 2025, then soared by 68.06% to -$138.0 million in 2026.
  • Per Business Quant, the three most recent readings for MRK's Non Operating Income are -$138.0 million (Q1 2026), -$432.0 million (Q4 2025), and $238.0 million (Q3 2025).